Thirty years ago, drug users flocked to a website called Erowid to describe experiences on everything from Advil to LSD. Today it’s become a goldmine for researchers and governments.
“I am melting, help me.” This is not only an unusual plea for assistance. It’s also the title of a “trip report”: one person’s experience with the powerful dissociative drug phencyclidine (known as PCP). And it’s just one of many thousands of mind-bending anecdotes filed to Erowid, a website that, since the early days of the internet, has built one of the world’s most influential records of drug use and its effects.
This year marks the 30th anniversary of the scrappy, grassroots project, which hosts data on everything from caffeine to cannabis to paracetamol (also known as Tylenol) to heroin, like a Wikipedia on all things pharmaceutical. Users post information about purifying street drugs, rolling joints and the health implications of drug misuse. Visitors to the site can find information about drug toxicology and interactions between chemicals. They can even wade through the archives of Albert Hoffman, the Swiss chemist who first synthesised lysergic acid diethylamide – or LSD.
But perhaps most intriguing of all are the 45,000-plus trip reports in the “Experience Vault”. These hallucinatory tales, with titles such as “Tripping Alone on 1.5 Grams From Hell”, “The Weekend At The Edge Of The Universe” and “The Thumbprint”, where an unfortunate soul loses their mind on a drug related to LSD called AL-LAD, do not just make for idle internet fodder. They have become vital for academic research, especially for esoteric and illegal substances where clinical data does not exist or is challenging to obtain.
“People publishing their personal experiences and experimenting outside of the legal and academic bubble has led to the science, in many ways,” says David Luke, associate professor of psychology at the University of Greenwich in the UK who studies psychedelics and has conducted clinical trials using microdoses of LSD. “There was so little published academic research and so few resources for exploring the use of psychoactive drugs that Erowid was invaluable for research, and to understand issues around safety and experiences.”
Today, the social stigma around some types of drug use has softened to the point that Ayahuasca ceremonies, mushrooms and ketamine have even become a fixture in some corners of the business world. While these substances are still illegal in many countries, a growing number of places are choosing to decriminalise drugs that were previously subject to extensive crack downs. In recent years, psychedelics have also gathered renewed interest from the scientific community as a potential approach for treating conditions such as post-traumatic stress disorder. Their use, however, remains controversial and in some places unregulated therapeutic use of these drugs has led to tragedy.
Back in 1995, when Erowid was founded, psychedelics were very much of the underground. This was a hostile time for drug reform, just over a decade since US president Ronald Reagan had expanded the war on drugs.